310 related articles for article (PubMed ID: 17373771)
1. In vitro and in vivo evaluation of a novel 99mTc(CO)3-pyrazolyl conjugate of cyclo-(Arg-Gly-Asp-d-Tyr-Lys).
Alves S; Correia JD; Gano L; Rold TL; Prasanphanich A; Haubner R; Rupprich M; Alberto R; Decristoforo C; Santos I; Smith CJ
Bioconjug Chem; 2007; 18(2):530-7. PubMed ID: 17373771
[TBL] [Abstract][Full Text] [Related]
2. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
[TBL] [Abstract][Full Text] [Related]
3. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.
Haubner R; Wester HJ; Burkhart F; Senekowitsch-Schmidtke R; Weber W; Goodman SL; Kessler H; Schwaiger M
J Nucl Med; 2001 Feb; 42(2):326-36. PubMed ID: 11216533
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer.
Liu S; Hsieh WY; Jiang Y; Kim YS; Sreerama SG; Chen X; Jia B; Wang F
Bioconjug Chem; 2007; 18(2):438-46. PubMed ID: 17341108
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of a Technetium-99m-labeled cyclic RGD peptide as a specific marker of alpha(V)beta(3) integrin for tumor imaging.
Su ZF; Liu G; Gupta S; Zhu Z; Rusckowski M; Hnatowich DJ
Bioconjug Chem; 2002; 13(3):561-70. PubMed ID: 12009947
[TBL] [Abstract][Full Text] [Related]
6. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
7. Tumor uptake of the RGD dimeric probe (99m)Tc-G3-2P4-RGD2 is correlated with integrin αvβ3 expressed on both tumor cells and neovasculature.
Liu Z; Jia B; Shi J; Jin X; Zhao H; Li F; Liu S; Wang F
Bioconjug Chem; 2010 Mar; 21(3):548-55. PubMed ID: 20184307
[TBL] [Abstract][Full Text] [Related]
8. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC
Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640
[TBL] [Abstract][Full Text] [Related]
9. Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting.
Haubner R; Wester HJ; Reuning U; Senekowitsch-Schmidtke R; Diefenbach B; Kessler H; Stöcklin G; Schwaiger M
J Nucl Med; 1999 Jun; 40(6):1061-71. PubMed ID: 10452325
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptides for human melanoma imaging.
Yang J; Guo H; Miao Y
Nucl Med Biol; 2010 Nov; 37(8):873-83. PubMed ID: 21055617
[TBL] [Abstract][Full Text] [Related]
11. A (99m)Tc(CO)(3)-labeled pyrazolyl-alpha-melanocyte-stimulating hormone analog conjugate for melanoma targeting.
Raposinho PD; Correia JD; Alves S; Botelho MF; Santos AC; Santos I
Nucl Med Biol; 2008 Jan; 35(1):91-9. PubMed ID: 18158948
[TBL] [Abstract][Full Text] [Related]
12. Melanoma targeting with alpha-melanocyte stimulating hormone analogs labeled with fac-[99mTc(CO)3]+: effect of cyclization on tumor-seeking properties.
Raposinho PD; Xavier C; Correia JD; Falcão S; Gomes P; Santos I
J Biol Inorg Chem; 2008 Mar; 13(3):449-59. PubMed ID: 18183429
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and comparative assessment of a labeled RGD peptide bearing two different ⁹⁹mTc-tricarbonyl chelators for potential use as targeted radiopharmaceutical.
Psimadas D; Fani M; Gourni E; Loudos G; Xanthopoulos S; Zikos C; Bouziotis P; Varvarigou AD
Bioorg Med Chem; 2012 Apr; 20(8):2549-57. PubMed ID: 22445386
[TBL] [Abstract][Full Text] [Related]
14. A novel concept of radiosynthesis of a (99m)Tc-labeled dimeric RGD peptide as a potential radiotracer for tumor imaging.
Mittal S; Bhadwal M; Chakraborty S; Sarma HD; Banerjee S; Pillai MR
Bioorg Med Chem Lett; 2013 Mar; 23(6):1808-12. PubMed ID: 23414841
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of linear and cyclic 99mTc-RGD peptides for targeting of integrins in tumor angiogenesis.
Fani M; Psimadas D; Zikos C; Xanthopoulos S; Loudos GK; Bouziotis P; Varvarigou AD
Anticancer Res; 2006; 26(1A):431-4. PubMed ID: 16475729
[TBL] [Abstract][Full Text] [Related]
16. A new cyclic RGD peptide dimer for integrin αvβ3 imaging.
Ma H; Hao P; Zhang L; Ma C; Yan P; Wang RF; Zhang CL
Eur Rev Med Pharmacol Sci; 2016; 20(4):613-9. PubMed ID: 26957261
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization, and biological evaluation of (99m) Tc(CO)3 -labeled peptides for potential use as tumor targeted radiopharmaceuticals.
Baishya R; Nayak DK; Chatterjee N; Halder KK; Karmakar S; Debnath MC
Chem Biol Drug Des; 2014 Jan; 83(1):58-70. PubMed ID: 23679852
[TBL] [Abstract][Full Text] [Related]
18. Novel 99mTc '4 + 1' peptide conjugates: tuning the biodistribution by variation of coligands.
Kunstler JU; Seidel G; Bergmann R; Gniazdowska E; Walther M; Schiller E; Decristoforo C; Stephan H; Haubner R; Steinbach J; Pietzsch HJ
Eur J Med Chem; 2010 Sep; 45(9):3645-55. PubMed ID: 20570022
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]